Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Topic: Varsome Insights

Aceragen, a biopharmaceutical company specializing in the development of treatments for rare genetic conditions, recently shared their novel approach to mapping Farber disease prevalence at ASHG 2022. Using VarSome Insights, the team were able to...

VarSome Insights

Aceragen Maps Rare Disease Prevalence with VarSome Insights

By Xanthippi Papakonstanti on March 2, 2023

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Reclassifying VUS

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Building the best in variant classification

Company News listing page

Categories

Stay up to date

Topic: Varsome Insights

Aceragen Maps Rare Disease Prevalence with VarSome Insights